Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076348 · ClinicalTrials.gov registry record
Model 4965 Post-Approval Study
A clinical trial of Heart Failure and Bradycardia, sponsored by Medtronic.
- Completed
- Registry status
- 73
- Enrollment target
- 20
- Study locations
NCT01076348 is a study of Heart Failure and Bradycardia that has completed, run by Medtronic. The registered enrollment target is 73 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 8 states.
The verdict
NCT01076348, a study of Heart Failure and Bradycardia, has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
- 20
- Study locations
Study Summary
Safety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).
Conditions Studied
Study Locations (20)
California
- - Bakersfield
- - Chula Vista
- - Downey
- - East Palo Alto
- - Los Angeles
- - Salinas
- - Torrance
- - Van Nuys
Florida
- - Clearwater
- - Jacksonville
- - Melbourne
- - Ocala
Arizona
- - Phoenix
- - Scottsdale
Colorado
- - Colorado Springs
- - Denver
Alabama
- - Birmingham
Alaska
- - Anchorage
Arkansas
- - Little Rock
District of Columbia
- - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 1996-09 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01076348
The ClinicalTrials.gov registry entry for NCT01076348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01076348 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT01076348 about?
NCT01076348 is a clinical study titled "Model 4965 Post-Approval Study". Safety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).
What is the current status of trial NCT01076348?
This trial is currently completed. The enrollment target is 73 participants. The study started on 1996-09. Estimated completion is 2011-04.
What conditions does trial NCT01076348 study?
This clinical trial studies the following conditions: Heart Failure, Bradycardia, Arrhythmia, Pacing.
Who is sponsoring clinical trial NCT01076348?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01076348 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.